Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 118Myelodysplastic Syndromes 107Lymphoma, Non-Hodgkin 90Leukemia, Lymphocytic, Chronic, B-Cell 85Hodgkin Disease 84Leukemia 81Multiple Myeloma 80Lymphoma, Mantle-Cell 63Lymphoma 63Lymphoma, Follicular 59Leukemia, Myelogenous, Chronic, BCR-ABL Positive 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 50Lymphoma, Large B-Cell, Diffuse 49Hematologic Neoplasms 42Congenital Abnormalities 42Lymphoma, Large-Cell, Immunoblastic 36Leukemia, Myeloid, Accelerated Phase 35Leukemia, Myeloid, Chronic-Phase 34Anemia, Refractory, with Excess of Blasts 34Waldenstrom Macroglobulinemia 33Primary Myelofibrosis 32Leukemia, Biphenotypic, Acute 32Lymphoma, Large-Cell, Anaplastic 28Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Dendritic Cell Sarcoma, Interdigitating 26

Interventions

fludarabine phosphate 4Sensitivity and Specificity 3Cyclophosphamide 3Antigens, CD19 3ibrutinib 2Whole-Body Irradiation 2Mycophenolic Acid 2Immunotherapy, Adoptive 2Etoposide 2pevonedistat 1obinutuzumab 1nelarabine 1letermovir 1carmustine, poliferprosan 20 drug combination 1Tacrolimus 1Stem Cell Transplantation 1Specimen Handling 1Pharmacogenomic Variants 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Leukapheresis 1Lenalidomide 1Hematopoietic Stem Cell Transplantation 1Cytarabine 1Cyclosporins 1Cyclosporine 1Carmustine 1Blood Component Removal 1Biopsy 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Prolymphocytic, B-Cell × Whole-Body Irradiation × Clear all
NCT01008462 2019-06-11

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
16 enrolled 15 charts
LymphoidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, B-Cell

NCT00060424 2017-12-08

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
21 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡